Patents Represented by Attorney Carolyn D. Moon
  • Patent number: 5545660
    Abstract: This invention relates to novel hydrazide acyl hydrazinium derivatives of certain 3,4-dihydro-2H-1-benzopyrans of the formula ##STR1## the stereoisomers and mixtures thereof, their inner salts, and the pharmaceutically acceptable salts thereof whereinR is H or C.sub.1-6 alkyl,R.sub.1 is C.sub.1-6 alkyl,R.sub.2 is H or --C(O)R,R.sub.3 and R.sub.4 are independently C.sub.1-6 alkyl;R.sub.5 is C.sub.1-6 alkyl, or ##STR2## with R.sub.8 being H or halogeno, n is zero, 1, 2, or 3 andis a halide, --S(O).sub.3 R.sub.6, or nothing when the inner salt is formedR.sub.6 is H, C.sub.1-6 alkyl, phenyl or 4-methylphenyl,to the intermediates, processes and techniques for their preparation, to their ability to manifest the property of being free radical scavengers, and to their end-use application in the treatment of disease conditions capable of being ameliorated by free radical scavengers.
    Type: Grant
    Filed: October 6, 1994
    Date of Patent: August 13, 1996
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: J. Martin Grisar, Margaret A. Petty, Frank Bolkenius
  • Patent number: 5536732
    Abstract: This invention relates to novel N-derivatives of 1-deoxy nojirimycin, to the method for their preparation and to their use in the treatment of diabetes and the use against retro-viruses, particularly in the treatment of acquired immuno-deficiency syndrome (AIDS).
    Type: Grant
    Filed: July 14, 1993
    Date of Patent: July 16, 1996
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Brigitte Lesur, Jean-Bernard Ducep, Charles Danzin
  • Patent number: 5534551
    Abstract: A compressed tablet comprising aminoguanidine or a pharmaceutically acceptable salt thereof and a suitably compatible binder prepared by spray drying techniques from an aminoguanidine solution, and methods of making same.
    Type: Grant
    Filed: December 22, 1994
    Date of Patent: July 9, 1996
    Assignee: Hoechst Marion Roussel, Inc.
    Inventors: Phillip E. Page, Jonathan Berman, Janet M. Pence, Sharon K. Minish
  • Patent number: 5523442
    Abstract: Fluorinated silylated aromatic compounds, their intermediates, methods of use in treating diseases associated with deficiencies of cholinergic transmission in the central nervous system and methods for their preparation are disclosed.
    Type: Grant
    Filed: July 18, 1995
    Date of Patent: June 4, 1996
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Jean-Noel Collard, Jean-Marie Hornsperger
  • Patent number: 5512698
    Abstract: This invention relates to a novel synthesis of 4-amino-5-hexenoic acid by thermal rearrangements, and to the novel intermediates produced thereby.
    Type: Grant
    Filed: April 11, 1995
    Date of Patent: April 30, 1996
    Assignee: Merrell Pharmaceuticals Inc.
    Inventor: Patrick Casara
  • Patent number: 5510373
    Abstract: This invention relates to certain hydroxy derivatives of 3,4-dihydro-2,5,7,8-tetraalkyl-2H-1-benzopyran-2-carboxylic acids and the lactones thereof, to the processes and intermediates useful for their preparation and to their use as free radical scavengers useful in the treatment of tissue damage implicated with free oxygen radicals.
    Type: Grant
    Filed: October 5, 1994
    Date of Patent: April 23, 1996
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: J. Martin Grisar, Margaret A. Petty, Frank Bolkenius
  • Patent number: 5508280
    Abstract: This invention relates to novel derivatives of 5H-dibenzo (a,d)cycloheptenes, to the processes for their preparation, to their muscarinic receptor antagonist properties and to their end-use application for treating Parkinson's Disease, tardive dyskinesia, and motion sickness.
    Type: Grant
    Filed: January 30, 1995
    Date of Patent: April 16, 1996
    Assignee: Merrell Pharmaceuticals, Inc.
    Inventors: Marcel Hibert, Luc Van Hijfte, Mary Richards, Paul Moser
  • Patent number: 5508287
    Abstract: This invention relates to 5-chloro-2,3-dihydro-2,2-dimethylbenzofuran-7-carboxylic acid-octahydro-3-hydroxy-2,6-methano-2H-quinolizin-8-yl ester (I), a novel 5-HT.sub.3 -receptor antagonist, its method of preparation, and to its end-use application in the treatment or radio- and chemo-therapeutically-induced nausea and vomiting, in the treatment or pain associated with migraine, in the treatment of cognitive disorders, in treating hallucinatory endogenous psychoses or the type manifested in patients suffering from schizophrenia and mania, for irritable bowel syndrome, and to combat drug abuse.
    Type: Grant
    Filed: August 16, 1994
    Date of Patent: April 16, 1996
    Assignee: Merrell Pharmaceuticals Inc.
    Inventor: Maurice W. Gittos
  • Patent number: 5504078
    Abstract: This invention relates to novel polyglycosidyl derivatives of 1-deoxy-nojirimycin, to the processes for their preparation and to their end-use applications, particularly as to their use in the treatment of diabetes.
    Type: Grant
    Filed: December 7, 1992
    Date of Patent: April 2, 1996
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Jean-Bernard Ducep, Charles Danzin
  • Patent number: 5484810
    Abstract: This invention relates to alkylated sulfonium alkylene derivatives of certain 2H-1-benzopyrans, to the intermediates and processes useful for their preparation, to their free-radical scavenger and cardioprotective properties and to their end-use application as therapeutic agents.
    Type: Grant
    Filed: February 28, 1995
    Date of Patent: January 16, 1996
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: J. Martin Grisar, Margaret A. Petty, Frank Bolkenius
  • Patent number: 5473099
    Abstract: This invention relates to a novel synthesis of 4-amino-5-hexenoic acid by thermal rearrangements, and to the novel intermediates produced thereby.
    Type: Grant
    Filed: April 11, 1995
    Date of Patent: December 5, 1995
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Patrick Casara
  • Patent number: 5440065
    Abstract: This invention relates to a novel synthesis of 4-amino-5-hexenoic acid by thermal rearrangements, and to the novel intermediates produced thereby.
    Type: Grant
    Filed: July 22, 1994
    Date of Patent: August 8, 1995
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Patrick Casara
  • Patent number: 5380936
    Abstract: This invention relates to a novel synthesis of 4-amino-5-hexenoic acid by thermal rearrangements, and to the novel intermediates produced thereby.
    Type: Grant
    Filed: January 19, 1994
    Date of Patent: January 10, 1995
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Patrick Casara
  • Patent number: 5371093
    Abstract: Piperidinyl thiacyclic derivatives ##STR1## wherein X, Y, R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are defined in the specification. useful in the treatment of allergic diseases and diseases responding to antagonism of 5HT.sub.2 receptors, pharmaceutical compositions and a methods of treatment using these compounds.
    Type: Grant
    Filed: February 24, 1994
    Date of Patent: December 6, 1994
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Albert A. Carr, George D. Maynard, John M. Kane, Hsien C. Cheng, Mark W. Dudley
  • Patent number: 5270336
    Abstract: Derivatives of 3,4-dihydroxy-2,5-dihydrofuran-5-ones, intermediates and processes useful for their preparation are disclosed. These compounds are useful as free-radical scavengers and exhibit cellular protective properties.
    Type: Grant
    Filed: August 26, 1992
    Date of Patent: December 14, 1993
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Gilbert Marciniak, J. Martin Grisar
  • Patent number: 5252587
    Abstract: This invention relates to novel N-derivatives of 1-deoxy nojirimycin, to the method for their preparation and to their use in the treatment of diabetes and the use against retro-viruses, particularly in the treatment of acquired immuno-deficiency syndrome (AIDS).
    Type: Grant
    Filed: June 15, 1992
    Date of Patent: October 12, 1993
    Assignee: Merrell Dow Pharmaceuticals, Inc.
    Inventors: Brigitte Lesur, Jean-Bernard Ducep, Charles Danzin
  • Patent number: 5182387
    Abstract: Novel bis-dibenzoazepine compounds useful in the treatment of malaria and drug-resistant malaria.
    Type: Grant
    Filed: October 30, 1991
    Date of Patent: January 26, 1993
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Jules Freedman, Alan J. Bitonti
  • Patent number: 5175188
    Abstract: Derivatives of 3,4-dihydroxy-2,5-dihydrofuran-5-ones, intermediates and processes useful for their preparation are disclosed. These compounds are useful as free-radical scavengers and exhibit cellular protective properties.
    Type: Grant
    Filed: January 10, 1992
    Date of Patent: December 29, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Gilbert Marciniak, J. Martin Grisar
  • Patent number: 5109006
    Abstract: This invention relates to novel derivatives of 1,7'-[imidazo-[1,2-a]pyridine]5'-(6'H)ones, to the method for their preparation and to their use as anti-hypertensive, anxiety, anti-depressant and anti-migraine agents, and to their use as appetite regulators useful for the treatment of anorexia and obesity.
    Type: Grant
    Filed: August 22, 1991
    Date of Patent: April 28, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Marcel Hibert
  • Patent number: 5097023
    Abstract: This invention relates to novel N-glycosyl derivatives of 1,4-dideoxy-1,4-imino-D-arabinitol, to the chemical processes for their preparation, to their .alpha.-glucosidase inhibiting properties, and to their end-use application in the treatment of diabetes, obesity and those diseases associated with retroviruses, particularly the HIV virus reported to be the causative of the acquired immune deficiency syndrome (AIDS).
    Type: Grant
    Filed: September 17, 1990
    Date of Patent: March 17, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Jean-Bernard Ducep, Charles Danzin